Gyre Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 4.4, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Gyre Therapeutics Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 83 days, from 82 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 439 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2964, from overall ranking in the first quarter 2026 at 3281.

What is Receivable Turnover Ratio?
What is Gyre Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GYRE Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	12.64 %	12.82 %	57.97 %	25.67 %	24.86 %
Y / Y Revenue Change	8.72 %	2.09 %	33.45 %	19.92 %	6.13 %
Receivable Turnover Ratio (TTM)	4.4	4.45	4.54	4.71	4.76
GYRE's Total Ranking	# 2964	# 3281	# 3049	# 3047	# 3031
Accounts Receivable average collection period days	83	82	80	78	77
Seq. Receivable Change	21.78 %	-26.56 %	19.92 %	5.02 %	21.98 %
Seq. Revenue Change	29.25 %	-39.46 %	21.7 %	14.17 %	21.37 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 133
Healthcare Sector	# 440
Overall Market	# 2964

Receivable Turnover Ratio Statistics
High	Average	Low
14.27	4.53	0.85
(Mar 31 2018)		(Jun 30 2016)

GYRE Company Profile • Back to GYRE Efficiency Comparisons • Compare GYRE Receivables Turnover Ratio to its Competitors

Financial Statements
Gyre Therapeutics Inc 's Accounts Receivable	$ 28 Millions	Visit GYRE's Balance sheet
Gyre Therapeutics Inc 's Sales TTM	$ 119 Millions	Visit GYRE's Income Statement
Sources of GYRE's Revenues		Visit GYRE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
GYRE's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
GYRE's Growth Rates	GYRE's Roa	GYRE's Inventory Turnover Ratio	GYRE's Dividend Comparisons
GYRE's Profitability Ratios	GYRE's Roi	GYRE's Asset Turnover Ratio	GYRE's Dividend Growth
GYRE's Valuation Ratios	GYRE's Roe	GYRE's Financial Strength Ratios	GYRE's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Catheter Precision Inc	11.62	$ 1.915 Millions	$ 0.165 Millions
Nrc Health	11.35	$ 139.996 Millions	$ 12.337 Millions
Picard Medical Inc	11.34	$ 5.983 Millions	$ 0.528 Millions
Premier Air Charter Holdings Inc	10.66	$ 31.562 Millions	$ 2.961 Millions
Lifeloc Technologies Inc	10.48	$ 9.269 Millions	$ 0.884 Millions
Addus Homecare Corp	10.23	$ 1,475.610 Millions	$ 144.195 Millions
Radnet Inc	10.11	$ 2,268.932 Millions	$ 224.447 Millions
Encompass Health Corporation	9.57	$ 6,206.100 Millions	$ 648.325 Millions
Harmony Biosciences Holdings inc	9.22	$ 960.191 Millions	$ 104.164 Millions
Ardent Health Inc	9.16	$ 6,405.940 Millions	$ 699.363 Millions
Bioaffinity Technologies Inc	9.11	$ 5.901 Millions	$ 0.648 Millions
Guardant Health Inc	8.84	$ 1,183.105 Millions	$ 133.772 Millions
Scientific Industries Inc	8.83	$ 5.728 Millions	$ 0.649 Millions
Cannapharmarx Inc	8.65	$ 1.699 Millions	$ 0.196 Millions
Septerna Inc	8.64	$ 98.882 Millions	$ 11.445 Millions
10x Genomics Inc	8.63	$ 616.566 Millions	$ 71.463 Millions
Pediatrix Medical Group Inc	8.54	$ 1,950.625 Millions	$ 228.297 Millions
Ensign Group Inc	8.50	$ 5,486.708 Millions	$ 645.470 Millions
Inogen Inc	8.47	$ 354.304 Millions	$ 41.817 Millions
Axogen inc	8.42	$ 251.174 Millions	$ 29.846 Millions
Adapthealth Corp	8.14	$ 3,226.709 Millions	$ 396.643 Millions
Atricure Inc	8.08	$ 567.747 Millions	$ 70.232 Millions
Alphatec Holdings Inc	7.94	$ 814.780 Millions	$ 102.662 Millions
Tenet Healthcare Corp	7.92	$ 21,812.000 Millions	$ 2,752.500 Millions
Henry Schein Inc	7.91	$ 13,602.000 Millions	$ 1,719.000 Millions
Pacs Group Inc	7.78	$ 5,551.038 Millions	$ 713.483 Millions
Vycor Medical Inc	7.68	$ 1.807 Millions	$ 0.235 Millions
Idexx Laboratories Inc	7.65	$ 4,553.792 Millions	$ 595.549 Millions
Sharps Technology Inc	7.65	$ 2.468 Millions	$ 0.323 Millions
Natera Inc	7.61	$ 2,707.077 Millions	$ 355.618 Millions

Date modified: 2026-08-14T20:17:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.